IP Library Granted Patent US 7,226,620
Granted Patent B2
US 7,226,620 · App. 11/122,151 · Granted Jun 5, 2007

Directly compressible tricalcium phosphate

Assignee: Rhodia Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,226,620
App. No.
11/122,151
Granted
Jun 5, 2007
Kind
B2
Abstract

A compressible tricalcium phosphate agglomerate comprises tricalcium phosphate particles, each having an outer surface, and a binder comprising a polyvinylpyrollidone, carrageenan, or a guar gum, supported on at least a portion of the outer surface of at least a portion of the tricalcium phosphate particles.

Claims (21)

1. A compressible tricalcium phosphate agglomerate, comprising, based on 100 pbw of the agglomerate: from about 90 to about 99 pbw tricalcium phosphate particles, each having an outer surface, and from about 1 to about 10 pbw a binder comprising a polyvinylpyrrolidone, carrageenan, guar gum, modified guar gum, or a mixture of guar gum and modified guar gum, supported on at least a portion of the outer surface of at least a portion of the tricalcium phosphate particles, and made by spray drying an aqueous slurry comprising the tricalcium phosphate particles and the binder.

2. The agglomerate of claim 1 , wherein the binder comprises polyvinyl pyrrolidone having a number average molecular weight of greater than or equal to about 30,000.

3. The agglomerate of claim 1 , wherein the binder comprises guar gum, a modified guar gum or a mixture thereof.

4. A directly compressible calcium dietary supplement composition, comprising, based on 100 pbw of the composition:

from about 20 to about 80 pbw of an agglomerate, according to claim 1 ,

from about 79 to about 10 pbw of particles of one or more calcium-containing materials other than the agglomerate,

from about 0.5 to about 8 pbw of a disintegrant, and

from about 0.5 to about 2 pbw of a lubricant.

5. The composition of claim 4 , wherein the particles of one or more calcium-containing materials other than the agglomerate are selected from the group consisting of calcium chelates, calcium salts, and mixtures thereof.

6. The composition of claim 4 , wherein the particles of one or more calcium-containing materials other than the agglomerate comprise tricalcium phosphate particles that exhibit a particle size distribution wherein less than or equal to 15 percent by weight of the particles have a particle size of greater than 40 mesh and less than or equal to 5 percent by weight of the particles have a particle size of less than 325 mesh.

7. The composition of claim 4 , wherein the lubricant is selected from the group consisting of fatty acid, hydrogenated vegetable oils, triglycerides of fatty acids, metal salts of fatty acids, glycols, talc, and mixtures thereof.

8. The composition of claim 4 , wherein the disintegrant is selected from the group consisting of sodium carboxylmethyl cellulose, starches, microcrystalline cellulose, soy protein, alginic acid, crosslinked polyvinylpyrrolidone, crosslinked sodium carboxymethylcellulose and mixtures thereof.

9. A process for making an oral dosage form of a calcium dietary supplement composition, comprising compressing the directly compressible calcium dietary supplement composition of claim 4 .

10. An oral dosage form of a calcium dietary supplement composition, made by compressing the composition of claim 4 .

11. The oral dosage form of claim 10 , wherein the oral dosage form exhibits a hardness of greater than or equal to 10 kilopond.

12. The oral dosage form of claim 10 , wherein the oral dosage form exhibits a hardness of greater than or equal to 15 kilopond.

13. The oral dosage form of claim 10 , wherein the oral dosage form exhibits a friability of less than 1%.

14. A chewable oral dosage form made by compressing a composition comprising a compressible tricalcium phosphate agglomerate, said compressible tricalcium phosphate agglomerate comprising, based on 100 pbw of the agglomerate, from about 90 to about 99 pbw tricalcium phosphate particles, each having an outer surface, and from about 1 to about 10 pbw a binder comprising a polyvinylpyrrolidone, carrageenan, guar gum, modified guar gum, or a mixture of guar gum and modified guar gum, supported on at least a portion of the outer surface of at least a portion of the tricalcium phosphate particles, and which agglomerate is made by spray drying an aqueous slurry comprising the tricalcium phosphate particles and the binder.

15. The oral dosage form of claim 14 , wherein the oral dosage form exhibits a hardness of greater than or equal to 10 kilopond.

16. The oral dosage form of claim 14 , wherein the oral dosage form exhibits a hardness of from about 12 to about 22 kilopond.

17. The oral dosage form of claim 14 , wherein the oral dosage form exhibits a hardness of from about 14 to about 16 kilopond.

Assignments (4)
PATENT SECURITY AGREEMENT (ABL) Recorded Feb 10, 2020
From: INNOPHOS, INC.; INNOPHOS, LLC
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051858/0131 →
PATENT SECURITY AGREEMENT (TL) Recorded Feb 10, 2020
From: INNOPHOS, INC.; INNOPHOS, LLC
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051858/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2019
From: RHODIA INC.
To: INNOPHOS, INC.
Reel/Frame 050610/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2005
From: HENDRICKS, LEWIS R.; JOBBINS, JILL MARIE; CAMARCO, WAYNE MARC
To: RHODIA INC.
Reel/Frame 016344/0526 →
Continuity (2)
Provisional Application 6056792600 · May 4, 2004
Related Publication 20050249813A1 · Nov 10, 2005